Avinger launches post-market study comparing OCT to IVUS in PAD treatments

Avinger (NSDQ:AVGR) said today it launched a post-market study comparing optical coherence tomography to intravascular ultrasound as used during interventions in the peripheral arteries. The Redwood City, Calif.-based company’s Lumivascular tech, including its Pantheris image-guided atherectomy device and Ocelot image-guided chronic total occlusion crossing catheters, use OCT for real-time intravascular imaging during interventions to treat peripheral artery disease. “As a regular user of diagnostic IVUS to plan treatment and assess results after the delivery of therapy, I have found that having an intravascular view of arterial structures and disease distribution leads to better results for my patients versus if I relied solely on fluoroscopy. Given the correlation between the use of intravascular imaging and clinical outcomes, I am excited to participate in a study that will help expand the incorporation of OCT into the treatment paradigm for peripheral interventions,” study investigator Dr. Edward Pavillard, who enrolled the first cases in the Scan study, said in a press release. Avinger said it is hopeful that the study will support an initiative to gain incremental reimbursement for OCT diagnostic imaging in the peripheral arteries, similar to the reimbursement currently provided for the use of intravascular ultrasound during such procedures. “OCT and IVUS have been well accepted imaging modalities for the diagnosis and treatment of atherosclerot...
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Imaging Vascular Avinger Source Type: news